China, Aug. 27 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical application of remimazolam–alfentanil combination in patients undergoing general anesthesia'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130878
Registration Time: 2026/08/26
Type: Interventional study
Primary Sponsor: The First Affiliated Hospital of Zhengzhou University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=245762
Published by HT Digital Content Services with permission from Health Daily Digest....